Nanosonics (ASX:NAN) Cash, Cash Equivalents, Marketable Securities : A$118.3 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Cash, Cash Equivalents, Marketable Securities?

Nanosonics's quarterly cash, cash equivalents, marketable securities increased from Dec. 2022 (A$99.29 Mil) to Jun. 2023 (A$112.16 Mil) and increased from Jun. 2023 (A$112.16 Mil) to Dec. 2023 (A$118.32 Mil).

Nanosonics's annual cash, cash equivalents, marketable securities declined from Jun. 2021 (A$96.03 Mil) to Jun. 2022 (A$94.51 Mil) but then increased from Jun. 2022 (A$94.51 Mil) to Jun. 2023 (A$112.16 Mil).

Nanosonics Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Nanosonics's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Cash, Cash Equivalents, Marketable Securities Chart

Nanosonics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

72.18

91.78

96.03

94.51

112.16

Nanosonics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															91.93	94.51	99.29	112.16	118.32

Nanosonics Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Nanosonics (ASX:NAN) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Nanosonics Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nanosonics's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics (ASX:NAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

NNCSF:USA OQS:Germany

Address

7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.nanosonics.com.au

Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.